Blanket Purchase Agreement HT942524A0014

Award Date 9/17/24
Last Date to Order 9/16/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) contract, awarded by the U.S. Department of Health and Human Services (HHS) to Integrated DNA Technologies, Inc. (IDT), enables the procurement of specialized biological products and services. Key deliverables include custom oligonucleotide synthesis, gene fragments, next-generation sequencing reagents, and other molecular biology tools. The contract supports a diverse range of federal agencies, including the National Institutes of Health (NIH), Centers...
This Blanket Purchase Agreement (BPA) was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT). The $10,000 firm-fixed-price contract provides custom DNA oligonucleotides, single-stranded DNA, gene blocks, small guide RNAs, and Cas9 enzyme to support NINDS research on the cellular and molecular mechanisms of frontotemporal dementia (FTD) and amyotrophic lateral...
This Blanket Purchase Agreement (BPA) is a single-award federal contract indefinite delivery vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the U.S. federal government. The contract, valued at a ceiling of $100,000,000, was awarded to Tecan Genomics, Inc., a Swiss-based manufacturer and distributor of automation and detection solutions for life science laboratories. The BPA is for the procurement of biological materials, specifically to...
The Defense Health Agency (DHA) awarded a $5.3 million single-award Blanket Purchase Agreement (BPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of specialized genomic and proteomic research tools. The BPA, which runs through September 2027, enables DHA to issue firm-fixed-price delivery orders for Biodiscovery's proprietary MYBAITS DNA reagents, custom DNA extraction products, sequencing kits, and other genomic research materials....
The Blanket Purchase Agreement (BPA) contract IDV, awarded to Sigma-Aldrich, Inc. by the Office of Logistics and Acquisition Operations (OLAO), a civilian federal agency, has a total ceiling value of $100,000,000 and a period of performance through October 31, 2025. The contract enables streamlined procurement of a wide range of chemicals, biological materials, and laboratory supplies needed to support scientific research and development across multiple government agencies, including the...
This Blanket Purchase Agreement (BPA) is a single-award indefinite delivery vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the U.S. federal government. The contract has a ceiling value of $10,000,000 and a period of performance through July 31, 2025. The prime contractor, Acgt Inc., is a for-profit, Asian-Pacific American-owned Subchapter S Corporation that provides a range of DNA sequencing and molecular biology services to government,...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) master contract between the Defense Health Agency (DHA) and Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $8,000,000 and an ultimate completion date of January 24, 2030. Under this single-award BPA, Cepheid provides the DHA with reagents, testing kits, and consumable supplies for molecular diagnostic testing. Key products include GeneXpert diagnostic systems,...
This federal Blanket Purchase Agreement (BPA) contract IDV, awarded by the U.S. Department of Health and Human Services (HHS) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, covers the provision of specialized molecular biology products and services in support of critical biomedical research and public health initiatives. The $10,000,000 single-award BPA, which does not have any set-aside designation, has an ultimate completion date of June 30, 2025 and was...
This Blanket Purchase Agreement (BPA) contract, awarded by the National Institute of Environmental Health Sciences and other civilian federal agencies, provides a vehicle for the recurring procurement of specialized medical and scientific products and services from Qiagen, LLC, a foreign-owned for-profit manufacturer. The primary products and services being delivered under this IDV include DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, chemical...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health Office of Logistics and Acquisition Operations to Genesee Scientific LLC, doing business as Genesee Scientific Corp, as a single-award indefinite delivery vehicle. The BPA has a ceiling value of $10,000,000.00 and a period of performance through September 30, 2025. The BPA provides for the procurement of laboratory supplies, including tips, tubes, enzymes,...

This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract has a ceiling value of $5,000,000 and a period of performance through September 16, 2029.

Under this BPA, IDT will deliver a variety of custom oligonucleotides, including DNA and RNA, gene fragments, next-generation sequencing products, primers, probes, and other reagents to support biomedical research, pandemic response, and public health initiatives across multiple federal agencies, such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Defense (DoD), and Department of Commerce. This BPA allows for the efficient procurement of IDT's specialized nucleic acid synthesis and genomics technologies to meet diverse federal needs in areas like genetics, SARS-CoV-2 research, COVID-19 testing, and marine genetics. The contract is a single-award, firm-fixed-price vehicle with no set-aside designation, reflecting IDT's position as a leading commercial supplier of these critical products and services to the government.

Generated 12/17/24, 9:04 AM